Clinical Trial Update: Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing fluticasone/formoterol K-haler medium strength to an ICS/LABA high-strength regimen in persistent asthma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Asthma

Drugs mentioned

• ICS/LABA High-Strength
• fluticasone/formoterol K-haler (Medium Strength) (fluticasone/formoterol)

Snippet

Sponsor: Mundipharma Pharmaceuticals S.L. | Conditions: Persistent Asthma | Phase 4 | Status: WITHDRAWN